Pilot Randomized Clinical Trial of Informational Support Versus Spiritual Care
PRaCTIS
1 other identifier
interventional
36
1 country
4
Brief Summary
The purpose of this study is to address the need for effective spiritual care support for patients with lung and gastrointestinal cancer. This study will examine how spiritual care affects spiritual wellbeing, anxiety, depression, satisfaction with spiritual care, and quality of communication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2025
CompletedStudy Start
First participant enrolled
September 9, 2025
CompletedFirst Posted
Study publicly available on registry
September 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
March 12, 2026
March 1, 2026
1.2 years
August 29, 2025
March 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Evaluation of feasibility of the Spiritual Care Assessment and Intervention (SCAI) framework vs informational support
Percentage of participants 1) enrolling; 2) completing 3 or more intervention sessions; 3) completing all study interviews
Visits 1-4, approximately weekly, within 3 months of enrollment
Evaluation of acceptability of the Spiritual Care Assessment and Intervention (SCAI) framework vs informational support
Acceptability Intervention Measure (AIM) This 4-item scale was developed as part of the Consolidated Framework for Implementation Research (CFIR) to evaluate intervention acceptability. Each item is rated on a 5-point scale, ranging from 1 (completely disagree) to 5 (completely agree). Responses are averaged to create a scale score. Higher scores indicate greater acceptability. This is a primary outcome for patients.
Visits 1-4, approximately weekly, within 3 months of enrollment; survey 1-week post-intervention
Test the effects of spiritual care on the outcome of spiritual wellbeing
Measured by the Functional Assessment of Chronic Illness Therapy - Spirituality (FACIT-Sp): Spiritual wellbeing will be assessed using the Functional Assessment of Chronic Illness Therapy-Spirituality (FACIT-Sp) 12-item measure. Each item is rated when considering the past week on a scale from 0 (not at all) to 4 (very much). Scores are the sum of individual items with total scores ranging from 0 to 48. Higher scores indicate higher spiritual well-being. This is a primary outcome for patients.
1, 6, and 12 weeks post intervention
Secondary Outcomes (6)
Effects of Spiritual Care Assessment and Intervention (SCAI) framework on anxiety
1, 6, and 12 weeks post intervention
Effects of Spiritual Care Assessment and Intervention (SCAI) framework on depression
1, 6, and 12 weeks post intervention
Effects of Spiritual Care Assessment and Intervention (SCAI) framework on satisfaction with spiritual care
1, 6, and 12 weeks post intervention
Effects of Spiritual Care Assessment and Intervention (SCAI) framework on meaning and purpose
1, 6, and 12 weeks post intervention
Effects of Spiritual Care Assessment and Intervention (SCAI) framework on religious coping
1, 6, and 12 weeks post intervention
- +1 more secondary outcomes
Study Arms (2)
Spiritual Care
EXPERIMENTALEligible and consented patients randomly assigned to the spiritual care intervention will receive a total of 4 visits with a board-certified or board-eligible chaplain. The intervention will utilize the Spiritual Care Assessment and Intervention (SCAI) framework. These visits will occur weekly for approximately 4 weeks either by telephone or through a HIPAA compliant video platform. The visits will last an average of 30 minutes each.
Informational Support
PLACEBO COMPARATOREligible and consented patients randomly assigned to the Informational Support comparator will receive 4 visits with a trained social worker. The comparator intervention will include discussion of topics including quality of life, financial resources, and evaluating health information. These visits will be conducted weekly for approximately 4 weeks. Each visit will take place for approximately 30 minutes.
Interventions
Participants in the Spiritual Care intervention discuss topics consistent with the Spiritual Care Assessment and Intervention (SCAI) framework including meaning and purpose, relationships, transcendence and peace, and self-worth and identity.
Participants in the Informational Support comparator arm discuss topics including quality of life, financial resources, and evaluating health information.
Eligibility Criteria
You may qualify if:
- ≥ 18 years old at the time of informed consent
- Ability to provide informed consent and HIPAA authorization
- Subject is at least 2 weeks post-diagnosis of an incurable and advanced stage (IV) lung or gastrointestinal (GI) malignancy and receiving cancer care at IU Simon Cancer Center, other IU Health Oncology Clinics, or Eskenazi Health Oncology Clinics
- Subject has a reliable phone and is willing to participate in 4 sessions with the chaplain
- Eastern Cooperative Oncology Group (ECOG) score ranging from 0 (fully active) to 3 (able to conduct limited self-care in bed or chair more than 50% of waking hours)
- Has low Spiritual Well-Being score of 35 or less on the FACIT-Sp
- Subject makes 2 or fewer errors on the Callahan 6-item cognitive screener administered during screening
You may not qualify if:
- Subject makes 3 or more errors on the Callahan 6-item cognitive screener administered during screening, or exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, intellectual disability, active psychosis) that in the judgment of the research team would preclude providing informed consent and study participation
- Currently receiving hospice care Note: subjects who enroll in hospice during the trial will have the option of continuing trial participation
- Have had a visit with a healthcare chaplain within the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- Walther Cancer Foundationcollaborator
Study Sites (4)
IU Health Joe and Shelly Schwarz Cancer Center
Carmel, Indiana, 46032, United States
Indiana University Melvin & Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202, United States
Sidney and Lois Eskenazi Hospital
Indianapolis, Indiana, 46202, United States
IU Health Arnett Hospital
Lafayette, Indiana, 47905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shelley Johns, PsyD
Indiana University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine, Research Scientist, Walther Scholar in Psycho-Oncology
Study Record Dates
First Submitted
August 29, 2025
First Posted
September 16, 2025
Study Start
September 9, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
April 1, 2027
Last Updated
March 12, 2026
Record last verified: 2026-03